Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer.
about
Molecular biology of lung cancer: clinical implicationsGenomic impact of cigarette smoke, with application to three smoking-related diseasesDNA methylation-based biomarkers for early detection of non-small cell lung cancer: an updateCDK4is a probable target gene in a novel amplicon at 12q13.3-q14.1 in lung cancerChromium cross-links histone deacetylase 1-DNA methyltransferase 1 complexes to chromatin, inhibiting histone-remodeling marks critical for transcriptional activationThe role of DNA methylation as biomarkers in the clinical management of lung cancer.p16(INK4a) suppression by glucose restriction contributes to human cellular lifespan extension through SIRT1-mediated epigenetic and genetic mechanisms.Air pollution and cancer: biomarker studies in human populations.Meta-analyses of gene methylation and smoking behavior in non-small cell lung cancer patients.Correlation between smoking history and molecular pathways in sporadic colorectal cancer: a meta-analysis.Methylation of the p16(INK4a) promoter region in telomerase immortalized human keratinocytes co-cultured with feeder cellsDetection of methylation of the RAR-β gene in patients with non-small cell lung cancer.Methylation of the DLEC1 gene correlates with poor prognosis in Japanese lung cancer patients.Regulation of the G1/S phase of the cell cycle and alterations in the RB pathway in human lung cancer.Identification of DLC-1 expression and methylation status in patients with non-small-cell lung cancer.Clinical significance of the p53 pathway and associated gene therapy in non-small cell lung cancers.Therapeutic targets in the ARF tumor suppressor pathway.Quantitative analysis of DNA methylation profiles in lung cancer identifies aberrant DNA methylation of specific genes and its association with gender and cancer risk factors.Gene-environment interaction in tobacco-related cancers.Hypermethylation of p16INK4a in Korean non-small cell lung cancer patients.Role of p14ARF and p15INK4B promoter methylation in patients with lung cancer: a systematic meta-analysis.CDKN2A/p16 inactivation mechanisms and their relationship to smoke exposure and molecular features in non-small-cell lung cancer.Long-term exposure to hexavalent chromium inhibits expression of tumor suppressor genes in cultured cells and in mice.Methylation profile in tumor and sputum samples of lung cancer patients detected by spiral computed tomography: a nested case-control study.Asbestos-associated genome-wide DNA methylation changes in lung cancer.Aberrant DNA methylation of some tumor suppressor genes in lung cancers from workers with chromate exposure.Molecular diagnosis and prognostic significance of lymph node micrometastasis in patients with histologically node-negative non-small cell lung cancer.Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer.CHFR hypermethylation and EGFR mutation are mutually exclusive and exhibit contrastive clinical backgrounds and outcomes in non-small cell lung cancer.Epigenetic alteration by the chemical substances, food and environmental factors.[Advances of DNA methylation in early diagnosis of lung cancer].Detection of serum Alu element hypomethylation for the diagnosis and prognosis of glioma.
P2860
Q24610335-C2A7AF89-007B-45BA-B94B-3DFFD5BF7424Q27027763-5D68057A-0377-4544-863D-DCA9C58C0D74Q28386334-B5694725-B143-4DA9-8A43-9523CE19C88FQ28530421-8F3C3159-E86B-4866-B7DE-04A6092CD173Q28756084-647116A2-C968-4005-ABA5-2AF679C25D63Q30317739-9BF6DFE2-0455-4605-A9BC-E9A3EDB4D25DQ33842306-4F89BC76-2093-4EA8-BC4D-079B20CE4C3BQ34445785-483C13DD-7891-4F7A-A753-5C40F48D72F3Q35160337-2AB9DE67-4AFA-48E3-98A8-3E813CD9DF9EQ35643491-BD536A83-F5CF-4205-948B-91E7DD7C9FB1Q35846204-4DBA397F-41A3-47A9-9984-B4207FAE997EQ35995676-4A9A7512-D35E-4C37-9EDE-B0A8C519880FQ36217021-332A1860-B12F-4B55-9A0E-0ED91F277B2CQ36448676-633B9BD9-A19C-41D9-ADD9-49C383179AFEQ36523868-B413D711-5245-413E-8F66-B9D4BEE91D9DQ36728827-B45FCF31-543D-4483-B90E-EEC5DA4119BBQ36879301-9EB5D61E-6BBD-4A57-BED2-FDD89B4D91E9Q37036306-CF8A3AE9-BB4D-4E69-92C3-78D2FFA689E3Q37190263-6648C282-E938-4695-A415-DC05D2944B6CQ37222495-603DEE21-D702-42D2-9EA0-A13DECBE4C30Q37420737-C06B815A-FF0F-4186-B4E5-118BF94A8946Q37633163-184BD698-553C-4EAF-AB9C-616E67FE2DDBQ42209563-2BB27E5D-077F-40EF-A69A-D11D157B551DQ46694347-2B1B4FF4-0000-4506-BAF5-775065CB2B3CQ48102302-C8FA2E51-8948-438B-8FC8-704F28ADB6FCQ53291177-6060909B-B998-4DE9-8B96-7C8EACB608E1Q54274131-AA33F442-3643-4CFF-8628-7901BC745CB2Q54568648-D1D8B1D3-66E0-4FFF-A2F3-4C33E3A77034Q54673900-23F93F1C-30D8-4DA4-B68D-FD6A43C03C8BQ55008611-07870D20-4EB9-4768-8818-ED6B456D1DEFQ55427539-F74A37A0-1646-4327-9846-AD3F5B6C8270Q55461647-BD8997E9-9910-4F0C-80EF-1763D3EE889E
P2860
Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Aberrant p16 promoter methylat ...... ith nonsmall cell lung cancer.
@en
Aberrant p16 promoter methylat ...... ith nonsmall cell lung cancer.
@nl
type
label
Aberrant p16 promoter methylat ...... ith nonsmall cell lung cancer.
@en
Aberrant p16 promoter methylat ...... ith nonsmall cell lung cancer.
@nl
prefLabel
Aberrant p16 promoter methylat ...... ith nonsmall cell lung cancer.
@en
Aberrant p16 promoter methylat ...... ith nonsmall cell lung cancer.
@nl
P2093
P356
P1476
Aberrant p16 promoter methylat ...... ith nonsmall cell lung cancer.
@en
P2093
Annamaria Kannio
Juozas R Lazutka
Kirsti Husgafvel-Pursiainen
Sisko Anttila
Sonata Jarmalaite
P304
P356
10.1002/IJC.11322
P577
2003-10-01T00:00:00Z